Presideo, Verisign partner, gain Medquist as customerPresideo, a firm specializing in digital identity management in healthcare, and Verisign, a firm concentrating on security infrastructure for e-business, have partnered to provide services to
Presideo, a firm specializing in digital identity management in healthcare, and Verisign, a firm concentrating on security infrastructure for e-business, have partnered to provide services to the healthcare industry. Verisign will combine its 24/7 managed trust services infrastructure with Presideos identity management products to develop online physician credentialing; biometric authentication; interoperability services; and a policy, legal, and business framework specific to healthcare. Presideo and Verisign will jointly market these security services.
The firms have already sold Medquist, a transcription services vendor owned by Philips, on their joint offering. Medquist will embed Internet security infrastructure and digital certificates into existing products and Medquist.net products.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.